Companies around the country are figuring out how to safely reopen office during the pandemic. The new normal might involve smartphone apps and badges to track employees.

The pandemic has devastated the job markets across the U.S. The April jobs report reveals the massive toll the crisis took on industries — from restaurants and retail to health care and automotive.

NPR's Mary Louise Kelly speaks with Brian Moynihan, the Bank of America CEO, about banks raking in fees from the Paycheck Protection Program.

Before the coronavirus crisis, there were briefly more women on American payrolls than men. That's no longer true. Women accounted for 55% of the increase in job losses last month.

Scientists have identified a mutated strain of the coronavirus that has been spreading for the last few months.

Researchers are testing sewage in hopes of getting a jump on COVID-19 outbreaks in communities — monitoring for when they begin and how quickly they spread.

Scientists are now trying to determine whether antibodies in the blood will protect people from contracting the coronavirus again. This question is crucial for the development of a vaccine.

NPR's global health reporter answers listener questions about how the coronavirus is mutating.

There are various studies looking at changes to the virus genome — and the possible impact on how the virus affects humans. Here's what we know (and don't yet know) about mutations.

And as summer nears, the question must be asked: Is it risky from a COVID-19 standpoint to go in a swimming pool?

A team of scientists at Oregon State University are trying to measure the true prevalence of the coronavirus in Corvallis, Ore., by taking a random sample of the population.

President Donald Trump expressed optimism that the United States will develop a vaccine to treat coornavirus by the end of the year. Trump made the prediction at a Fox News virtual town hall on Sunday, which is contrary to public health experts' assessment that it will take at least another year to make a breakthrough in anti-coronavirus vaccine development. "I think we're going to have a vaccin

British Prime Minister Boris Johnson was discharged from hospital on Sunday, when the country's coronavirus death toll passed a grim landmark of 10,000. Boris Johnson was tested positive for coronavirus with mild symptoms on March 27. He was admitted to St Thomas' Hospital in London after 10 days with "persistent symptoms" of coronavirus. He was moved to intensive care unit later as his symptoms

At a White House news conference on Wednesday, President Donald Trump described the coronavirus pandemic as the "worst attack" ever on the United States. "This is worse than Pearl Harbor, this is worse than the World Trade Center. There's never been an attack like this," he told reporters. Trump repeated pointing finger at China over the killer disease's global spread. "And it should have never

The Trump administration is preparing to wind down within weeks the White House taskforce that was formed to deal with the coronavirus pandemic in the country. This was announced by Vice President Mike Pence at a news conference Tuesday. He told reporters, "A reflection of the tremendous progress we've made as a country", the Trump administration was "starting to look at the Memorial Day [late Ma

The major U.S. index futures are currently pointing to a sharply higher opening on Friday, with stocks likely to add to the gains posted in the previous session.

The major U.S. index futures are currently pointing to a higher open on Tuesday, with stocks likely to move to the upside after ending the previous session mixed.

The coronavirus pandemic has so far infected 1.07 million people in the United States and has taken lives of more than 62,000.

Clever Leaves, a multinational operator and licensed producer of pharmaceutical-grade cannabis as well as hemp extracts, and Canopy LATAM Corp., a wholly owned subsidiary of Canadian cannabis company Canopy Growth Corp. (CGC, WEED.TO), said they have entered into a regional supply agreement.

BioNTech (BNTX) and its partner Pfizer (PFE) have started a phase I/II clinical trial in the U.S. for their BNT162 vaccine program to prevent COVID-19.

President Donald Trump on Monday announced a strategy to expand coronavirus testing facilities in the United States, which the White House described as a decisive step to ensure States have the testing system required to reopen the nation. The Trump Administration released its blueprint for State testing plans and rapid response programs as a follow up of the "Opening Up America Again" guidelines

The head of the Centers for Disease Control and Prevention has warned of a second wave of the novel coronavirus in the next winter, which, according to him, is likely to be even more devastating than the one that is raging across the globe. "We're going to have the flu epidemic and the coronavirus epidemic at the same time," CDC Director Robert Redfield said in an interview with The Washington Po

The number of people infected with coronavirus in the United States crossed the dreadful one million mark Wednesday, making up nearly one third of the global cases. With more than 58,000 deaths, more Americans have died of COVID-19 than in the Vietnam War. The pandemic has so far infected 10,12,583 people in the country, according to data compiled by the Center for Systems Science and Engineerin

While reporting financial results for the first quarter on Friday, energy company Avista Corp. (AVA) said it is lowering its consolidated earnings guidance for the full-year 2020 to reflect regulatory items, expected net impacts from COVID-19, and losses at our non-utility businesses.

NPR's Lulu Garcia-Navarro asks UNC coronavirus researcher Dr. Ada Adimora for the latest information concerning COVID-19.

U.K. stocks rose sharply on Tuesday as several countries tentatively eased restrictions on movement in a bid to revive global economies.

A team of scientists at Oregon State University are trying to measure the true prevalence of the coronavirus in Corvallis, Ore., by taking a random sample of the population.

NPR's Scott Simon speaks with Caitlin Flanagan about her new piece in The Atlantic called "I Thought Stage IV Cancer Was Bad Enough."